The Series B round was led by Leaps by Bayer to support clinical studies and technology development.
M
Medopad
Medopad develops digital health platforms and remote patient monitoring tools to advance proactive medicine.
£19.4MTotal raised
Medopad is a London-based health technology company that builds digital health platforms and remote patient monitoring tools for clinical research and care. It partners with healthcare systems and life science organisations to advance proactive medicine.
Filed accounts
Cash at bank
Members only
Total assets less current liabilities
Members only
Shareholders' funds
Members only
Employees
Members only
Cash, assets and headcount from Medopad's latest Companies House filing — with year-on-year movement, free with a Winfred account.
Categories
Founders
DV
Dan Vahdat
Founder and CEO
Dan brings founding and executive experience from Medopad and Huma, alongside involvement with the World Economic Forum.
LinkedInInvestors
Lb
Leaps by BayerLeadFunding history
£19.4M